Bulandres, Marites .

HRN: 20-88-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2024
CEFUROXIME 1.5GM (VIAL)
02/18/2024
02/24/2024
IV
1.5gm
Q8
Uti
02/19/2024
CEFUROXIME 500MG (TAB)
02/19/2024
02/26/2024
ORAL
500mg
BID
S/P Pelvic Laparotomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: